SCHEMBL5047907

SCHEMBL5047907

COC(=O)c1ccc(C(=O)NC(C)c2cccc(Br)c2)s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.58
HDAC4 P56524 3/20 0.58
HDAC1 Q13547 3/20 0.58
HDAC6 Q9UBN7 3/20 0.53
ALDH1A1 P00352 3/20 0.52
PRKACA P17612 2/20 0.51
GSK3A P49840 2/20 0.51
GSK3B P49841 2/20 0.51
RPS6KA3 P51812 2/20 0.51
ROCK1 Q13464 2/20 0.51
AURKB Q96GD4 2/20 0.51
CLK4 Q9HAZ1 2/20 0.51
CHEK1 O14757 1/20 0.51
AURKA O14965 1/20 0.51
MAP4K4 O95819 1/20 0.51
GRK5 P34947 1/20 0.51
CSNK1A1 P48729 1/20 0.51
CDK8 P49336 1/20 0.51
PRKX P51817 1/20 0.51
PRKCQ Q04759 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046005 0.84 HDAC3 (0.59) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL5046007 0.84 HDAC3 (0.59) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6030810 0.84 HDAC3 (0.76) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6030805 0.84 HDAC3 (0.76) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL4461433 0.81 ROCK1 (0.55) HDAC3HDAC4HDAC1HDAC6PRKACA
SCHEMBL5049377 0.79 PRKACA (0.53) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6030791 0.78 HDAC3 (0.57) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6030794 0.78 HDAC3 (0.57) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL4664658 0.78 HDAC3 (0.57) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6227427 0.77 ALDH1A1 (0.56) ALDH1A1L3MBTL1POLBF7F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396944-B2 Thiophene derivatives, their manufacture and use as pharmaceutical agents HOFFMANN-LA ROCHE INC. (US) 2008-07-08 US disclosed
US-20070232602-A1 Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents HOFFMAN-LA ROCHE INC. 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232602-A1 Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents TPMT, ABCB1, CYP3A5 HDAC3 3854/4885HDAC4 4101/4885HDAC1 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.